A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma
Table 1
The relationship between prognostic-related mitochondrial genes and clinicopathologic parameters.
Gene
Gender (male/female)
Grade (G1–2/G3–4)
Stage (I–II/III–IV)
T stage (T1–T2/T3–T4)
N stage (N0/NI–X)
M stage (M0/MI–X)
N
353/186
249/282
331/205
349/190
241/298
428/109
ACAD11
value
3.637
2.16
2.979
2.359
0.149
NA
value
<0.001
0.031
0.003
0.019
0.881
<0.001
ACADSB
value
1.475
NA
NA
6.841
0.135
4.957
value
0.141
<0.001
<0.001
<0.001
0.893
<0.001
BID
value
2.926
NA
6.911
6.304
0.558
3.497
value
0.004
<0.001
<0.001
<0.001
0.577
0.001
PYCR1
value
3.342
NA
NA
5.099
0.032
3.09
value
0.001
<0.001
<0.001
<0.001
0.974
0.002
SLC25A27
value
1.392
3.023
NA
NA
0.749
0.193
value
0.165
0.003
0.009
0.037
0.455
0.847
STAR
value
0.655
NA
4.251
4.485
0.491
3.346
value
0.513
0.007
<0.001
<0.001
0.624
0.001
NA: not available; nonparametric Mann–Whitney rank sum test. (The statistical method was -test or nonparametric Mann–Whitney rank sum test with only one test. The reported value was the value).
